High Prevalence of Obesity and Launch of Obesity Management Certificate Programs to Augment Growth of Weight Loss and Obesity Management Market

 

Weight Loss and Obesity Management Market

High prevalence of obesity is expected to propel growth of the global weight loss and obesity management market. For instance, the study, ‘Rising incidence of obesity in Saudi residents. A threatening challenge for the surgeons’, published in the International Journal of Health Sciences, in January 2018, reported obesity in 42% of the study population with low physical activity levels and unhealthy dietary habits. Moreover, launch of obesity management certificate programs is also expected to aid in growth of the market. For instance, in 2018, American Academy of PAs launched its Primary Care Obesity Management Certificate Program with a live workshop during AAPA Conference 2018 in New Orleans, U.S.

High prevalence of diabetes is expected to offer lucrative growth opportunities for players in the global weight loss and obesity management market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045. Moreover, emergence of Covid-19 is also expected to aid in growth of the market. For instance, in January 2021, The American Academy of Pediatrics (AAP) offered guidance on continuing obesity management during the current pandemic.

Competitive Analysis 

Major players operating in the global weight loss and obesity management market include, Novo Nordisk A/S, Takeda Pharmaceutical Company Ltd, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, VIVUS Inc., Herbalife Ltd., Apollo Endosurgery (U.S.), Amer Sports, Rhythm Pharmaceuticals, Inc., Brunswick Corporation, Cybex International, Duke Products & Services & Fitness Center, Ethicon Inc., Equinox, Inc., Johnson & Johnson Services, Inc., Kellogg Company, Life Time Fitness Inc., Medtronic, and NutriSystem, Inc.

Major players operating in the global weight loss and obesity management market are focused on approval and launch of new products to expand their product portfolio. For instance, in November 2020, Rhythm Pharmaceuticals, Inc. received the U.S. Food & Drug Administration approval for IMCIVREE (setmelanotide) for chronic weight management in adult and pediatric patients 6 years of age and older with obesity due to proopiomelanocortin, proprotein convertase subtilisin/kexin type 1 or leptin receptor deficiency.


Location: India

Comments

Post a Comment

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

Image
  Fitness equipment is any mechanical device or equipment used in sport or exercise to improve the physical performance or strength of that activity by providing either adjustable or constant levels of force, either of dynamic nature that is immediately available to exert (such as running) or of a static type that requires adjustments (such as a bicycle). Some common types of equipment are treadmills, elliptical machines, step machines, exercise bicycles, recumbent bikes, treadmill monitors, rowing machines, and many more. Fitness equipment is used in gyms and private home fitness facilities as well as public parks and recreational facilities. Fitness equipment for the home is designed to provide low-impact aerobic workouts. Some items are available for rent or sale on the Internet. Rowing machines and exercise bicycles can give an all-over body workout, while Schwinn exercise bicycles can be used to target specific muscles. Fitness equipment for home gyms can be classified into ...
Read more

The market for ureteral stents would benefit from the rising prevalence of urological diseases

Image
  A ureteral stent is a slender adaptable cylinder embedded straightforwardly into the ureter to forestall or cure block of the urinary entry from the ureter. The length of these stents utilized for grown-up quiet's reaches somewhere in the range of 30 and 24 inches. Furthermore, various distances across or sizes of stents are accessible, to suit distinctive ureter sizes. This permits treatment choices to be customized to the person, just as to the degree of obstacle. Urinary stents are made of either metal silicone or plastic. They are set straightforwardly into the bladder through the urethra valve. Ureteral stents can either be made percutaneously, through medical procedure or by methods for an outpatient strategy. Contingent upon the sort of ureter that is influenced, the technique can be either a solitary needle or numerous needles. The developing commonness of urological illnesses around the world is driving the development of the ureteral stents market . Development in t...
Read more

Increased Prevalence of Chronic Diseases and Stem Cell Therapy R&D to Drive Stem Cell Assay Market Growth

Image
  Stem cells are another age of specific cells which dislike the remainder of your body cells. A stem cell is an undifferentiated mass of tissue which has the astounding ability to increase uncertainly without separating as other body cells do. It is additionally recognized into various particular cells like bone cells (osteocytes), skin cells (melanocytes), platelets (leukocytes), nerves, and heart cells. Market Dynamics Expanding predominance of persistent infections is required to impel development of the worldwide stem cell assay market. For example, as indicated by the American Cancer Society, in 2019, there will be an expected 1,762,450 new malignancy cases analyzed and 606,880 disease passings in the U.S. In addition, adequacy of autologous hematopoietic stem cell relocate in treatment of different sicknesses is additionally expected to help in development of the market. For example, in November 2020, the National MS Society expressed that autologous hematopoietic stem c...
Read more